AbCellera Biologics (ABCL) News Today → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free ABCL Stock Alerts $3.95 +0.11 (+2.86%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnalysts Are Bullish on These Healthcare Stocks: ICU Medical (ICUI), AbCellera Biologics (ABCL)markets.businessinsider.com - May 8 at 5:33 PMBuy Rating Affirmed for AbCellera Biologics on Strong Financials and Promising Partnershipsmarkets.businessinsider.com - May 8 at 5:33 PMAbCellera Biologics (NASDAQ:ABCL) PT Lowered to $7.00 at KeyCorpmarketbeat.com - May 8 at 3:05 PMAbCellera Biologics (NASDAQ:ABCL) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPSmarketbeat.com - May 8 at 8:24 AMAbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcriptfool.com - May 8 at 8:18 AMQ1 2024 Abcellera Biologics Inc Earnings Callfinance.yahoo.com - May 8 at 8:18 AMABCL Stock Earnings: AbCellera Biologics Beats EPS, Misses Revenue for Q1 2024investorplace.com - May 7 at 10:05 PMAbCellera Biologics Inc (ABCL) Q1 2024 Earnings: Misses Revenue and Net Loss Estimatesfinance.yahoo.com - May 7 at 6:27 PMAbCellera Reports Q1 2024 Business Resultsbusinesswire.com - May 7 at 4:05 PMWhat Wall Street expects from AbCellera Biologics's earningsmarkets.businessinsider.com - May 6 at 10:12 AMAbCellera Biologics (NASDAQ:ABCL) Stock Price Up 7%americanbankingnews.com - May 5 at 4:34 AMAbCellera Biologics (NASDAQ:ABCL) Trading Up 7%marketbeat.com - May 3 at 9:54 PMInsider Stock Buying Reaches US$1.61m On AbCellera Biologicsfinance.yahoo.com - May 2 at 3:08 PMAbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companiesbusinesswire.com - May 1 at 9:00 AMAbCellera Biologics Inc. (NASDAQ:ABCL) Given Consensus Rating of "Buy" by Analystsamericanbankingnews.com - May 1 at 2:54 AMAbCellera Biologics (ABCL) to Release Earnings on Tuesdayamericanbankingnews.com - April 30 at 3:00 AMAbCellera Biologics (NASDAQ:ABCL) Sets New 52-Week Low at $3.76marketbeat.com - April 25 at 3:44 PMAbCellera Biologics (NASDAQ:ABCL) Trading 4.3% Higher marketbeat.com - April 24 at 6:15 PMAbCellera Biologics (NASDAQ:ABCL) Hits New 12-Month Low at $3.84marketbeat.com - April 18 at 10:58 AMAbCellera Biologics Inc. (ABCL)finance.yahoo.com - April 18 at 8:03 AMAbCellera Biologics Inc. (NASDAQ:ABCL) Shares Sold by Baillie Gifford & Co.marketbeat.com - April 10 at 8:34 AMAbCellera Biologics (NASDAQ:ABCL) Shares Up 5.1%marketbeat.com - April 9 at 3:19 PMAbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024businesswire.com - April 8 at 12:05 PMAbCellera Biologics Inc. (NASDAQ:ABCL) Receives Average Rating of "Buy" from Analystsmarketbeat.com - April 6 at 2:58 AMAbCellera to Report First Quarter 2024 Financial Results on May 7, 2024businesswire.com - April 3 at 4:05 PMAbCellera Biologics (NASDAQ:ABCL) Trading Down 3.8%marketbeat.com - April 1 at 2:58 PMThe 7 Best Penny Stocks to Buy in Q2 2024investorplace.com - March 27 at 4:30 PMBillionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocksfinance.yahoo.com - March 27 at 1:54 AMAbCellera Biologics (NASDAQ:ABCL) Stock Price Down 3.7%marketbeat.com - March 26 at 4:46 PMAbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024businesswire.com - March 19 at 4:05 PMAbCellera gains on antibody collaboration with Biogenmsn.com - March 11 at 4:45 PMAbCellera Biologics (NASDAQ:ABCL) Stock Price Up 4.8%marketbeat.com - March 11 at 11:52 AMSchonfeld Strategic Advisors LLC Acquires 211,000 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL)marketbeat.com - March 9 at 5:42 AMAbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024businesswire.com - March 5 at 4:30 PMTrexquant Investment LP Has $1.25 Million Position in AbCellera Biologics Inc. (NASDAQ:ABCL)marketbeat.com - March 5 at 7:53 AMBarclays PLC Sells 504,978 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL)marketbeat.com - March 3 at 4:11 AMAfter losing 38% in the past year, AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners must be relieved by the recent gainfinance.yahoo.com - February 29 at 8:14 AMAbCellera: Victim Of Its Own Successseekingalpha.com - February 28 at 12:36 PMFederated Hermes Inc. Cuts Position in AbCellera Biologics Inc. (NASDAQ:ABCL)marketbeat.com - February 26 at 7:21 AM3 Highly Rated Biotech Stocks to Buy for 300% Gainsinvestorplace.com - February 26 at 6:55 AMPiper Sandler Reaffirms Their Buy Rating on AbCellera Biologics (ABCL)markets.businessinsider.com - February 23 at 7:14 PMAbCellera Announces Resignation of Board Memberbusinesswire.com - February 23 at 4:30 PMABCL Mar 2024 4.000 callfinance.yahoo.com - February 23 at 2:14 PMABCL Mar 2024 5.000 callfinance.yahoo.com - February 23 at 12:41 PMAbCellera Biologics Inc. (NASDAQ:ABCL) Shares Bought by Dark Forest Capital Management LPmarketbeat.com - February 23 at 7:52 AMAbCellera Biologics Inc. to Post Q1 2024 Earnings of ($0.14) Per Share, Bloom Burton Forecasts (NASDAQ:ABCL)marketbeat.com - February 23 at 7:17 AMBenchmark Upgrades AbCellera Biologics (ABCL)msn.com - February 23 at 1:16 AMAbCellera Biologics Stock (NASDAQ:ABCL) Earnings Dates and Earning Callsbenzinga.com - February 22 at 8:16 PMAbCellera to Present at Upcoming Investor Conferences in Marchbusinesswire.com - February 22 at 8:15 PMObesity drugs to expand U.S. GDP by 1% in the coming years: Goldman Sachsmsn.com - February 22 at 3:56 PM Get AbCellera Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABCL and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide ABCL Media Mentions By Week ABCL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABCL News Sentiment▼-0.070.41▲Average Medical News Sentiment ABCL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABCL Articles This Week▼152▲ABCL Articles Average Week Get AbCellera Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABCL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MannKind News Today Prothena News Today Mirum Pharmaceuticals News Today Belite Bio News Today Spyre Therapeutics News Today Collegium Pharmaceutical News Today Ironwood Pharmaceuticals News Today Pacira BioSciences News Today Gemini Therapeutics News Today Homology Medicines News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABCL) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersUrgent Nvidia WarningAltimetryObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
